Germany's MediGene has signed yet another agreement for its treatment for genital warts, Veregen ointment (previously Polyphenon E), the latest deal being with Serbian company, Pharmanova, which will
The German biotech company MediGene has signed another licence and supply agreement for the commercialisation and marketing of Veregen (previously Polyphenon E) ointment for the treatment of genital w